Table 4.

Number of mutations per patient by treatment arm

No. of mutations per patientn (%)
Arm A: decitabine (n = 56)Arm B: decitabine + bortezomib (n = 62)All patients (N = 118)
02 (3.6)4 (6.5)6 (5.1)
115 (26.8)12 (19.4)27 (22.9)
213 (23.2)19 (30.6)32 (27.1)
316 (28.6)8 (12.9)24 (20.3)
47 (12.5)12 (19.4)19 (16.1)
52 (3.6)4 (6.5)6 (5.1)
61 (1.8)2 (3.2)3 (2.5)
70 (0.0)1 (1.6)1 (0.8)
Median (range)2 (0-6)2 (0-7)2 (0-7)